uspto-grants-1979_05 · 10.6084/m9.figshare.5104873.v1 · US04152435
查看IDENTITY
结构与身份
- 标准SMILES
- CC(C)=CC(C)=NNc1nncc2ccccc12
- InChIKey
- DQGFCLJXYFXXIJ-UHFFFAOYSA-N
- 分子式
- C14H16N4
- 平均分子量
- 240.3 g/mol
- 单同位素质量
- 240.13749653
COMPUTED
结构计算性质
- XLogP
- 3.1
- 极性表面积
- 50.2 Ų
- 氢键供体
- 1
- 氢键受体
- 4
- 可旋转键
- 3
- 重原子
- 18
- 形式电荷
- 0
- 复杂度
- 331
PHARMACOLOGY
药理信息
MeSH Pharmacological Classification
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Drugs used to cause dilation of the blood vessels.
ALIASES
名称与别名
Buterazine36798-79-5BudralazinaBudralazinumS0177QHV2B1-(2-(1,3-Dimethyl-2-butenylidene)hydrazino)phthalazineDJ-14614-Methyl-3-penten-2-one (1-phthalazinyl)hydrazone1(2H)-Phthalazinone, (1,3-dimethyl-2-butenylidene)hydrazoneRefChem:917692Budralazine1-[2-(4-methylpent-3-en-2-ylidene)hydrazin-1-yl]phthalazineBudralazine [INN:JAN]Budralazinum [INN-Latin]Budralazina [INN-Spanish]DJ 14611-(2-(4-Methylpent-3-en-2-ylidene)hydrazinyl)phthalazine1-[2-(4-Methylpent-3-en-2-ylidene)hydrazinyl]phthalazineUNII-S0177QHV2BDTXSID00865833
REACTIONS